These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1474290)

  • 1. Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice.
    Gelber RH; Murray LP; Siu P; Tsang M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):485-7. PubMed ID: 1474290
    [No Abstract]   [Full Text] [Related]  

  • 2. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal bactericidal dietary concentration of minocycline for Mycobacterium leprae-infected mice is very low and similar to its minimal inhibitory dietary concentration.
    Gelbert RH; Siu P; Tsang M; Murray LP
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):276-7. PubMed ID: 1522371
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice.
    Ebenezer GJ; Arumugam S; Job CK
    Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):245-9. PubMed ID: 12768925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide.
    Gelber RH
    Lepr Rev; 1987 Dec; 58(4):407-11. PubMed ID: 3323753
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cyclosporin A on bacterial growth and immunological responsiveness in BALB/c mice infected with Mycobacterium leprae.
    Tanaka M; Tanaka Y; Kohsaka K
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):598-604. PubMed ID: 1802942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of metabolism and growth of Mycobacterium leprae by gamma irradiation.
    Adams LB; Soileau NA; Battista JR; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):1-10. PubMed ID: 10834063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
    Xiong JH; Ji B; Perani EG; Pétinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):37-42. PubMed ID: 8189087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
    Gelber RH; Siu P; Tsang M; Murray LP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):760-3. PubMed ID: 1648889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cycloserine and structurally related compounds against M. leprae-infected mice.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):536-8. PubMed ID: 6399071
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal bactericidal concentration of clarithromycin against M. leprae.
    Gelber RH; Murray LP; Siu P; Tsang M
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):140-3. PubMed ID: 8189083
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of Mitsuda reaction to nude mouse and armadillo lepromin preparations using nine-banded armadillos.
    Job CK; Truman RW
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):18-22. PubMed ID: 10834065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ultraviolet light radiation on Mycobacterium leprae.
    Truman RW; Gillis TP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):11-7. PubMed ID: 10834064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary composition on growth of M. leprae in mouse footpads.
    Sanchez A; Foster RL
    Indian J Lepr; 1989 Oct; 61(4):432-6. PubMed ID: 2695574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.